Cargando…
Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial
INTRODUCTION: No licensed medications are available to treat vascular dementia (VaD). METHODS: Patients were randomly assigned to experimental groups (SaiLuoTong [SLT] 360 or 240 mg for groups A and B for 52 weeks, respectively) or placebo group (SLT 360 mg and 240 mg for group C only from weeks 27...
Autores principales: | Jia, Jianping, Wei, Cuibai, Chen, Shuoqi, Li, Fangyu, Tang, Yi, Qin, Wei, Shi, Lu, Gong, Min, Xu, Hui, Li, Fang, He, Jia, Song, Haiqing, Yang, Shanshan, Zhou, Aihong, Wang, Fen, Zuo, Xiumei, Chu, Changbiao, Liang, Junhua, Jia, Longfei, Gauthier, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021260/ https://www.ncbi.nlm.nih.gov/pubmed/29955654 http://dx.doi.org/10.1016/j.trci.2018.02.004 |
Ejemplares similares
-
A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia
por: Liu, Junguang, et al.
Publicado: (2022) -
Chinese Herbal Preparation SaiLuoTong Alleviates Brain Ischemia via Nrf2 Antioxidation Pathway–Dependent Cerebral Microvascular Protection
por: Fan, Xiao-Di, et al.
Publicado: (2021) -
A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
por: Steiner‐Lim, Genevieve Z., et al.
Publicado: (2023) -
Monetary costs of Alzheimer’s disease in China: protocol for a cluster-randomised observational study
por: Li, Fangyu, et al.
Publicado: (2017) -
The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease
por: Jia, Longfei, et al.
Publicado: (2020)